Esperion Home | Esperion Therapeutics, Inc.

What's Next

The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work.

image of man hiking

Latest Events

Past Events

Products

We’re reaching goals by creating innovative options to reduce LDL-cholesterol. Today, we have two treatments, approved in the U.S. and Europe, based on a unique mechanism of action that represent an important step forward. By partnering with strong commercial organizations, such as Daiichi-Sankyo, we’re working to enable broad access to our medicines globally.

Pipeline

We’re reaching goals by harnessing innovative science in order to explore new therapies that address both cardiovascular and cardiometabolic risk. As we look to the future, we’re working to build a pipeline of treatments that are not only focused on lowering cholesterol.

Cholesterol Education

We’re reaching goals by providing additional treatment options for those in need of LDL-cholesterol lowering. In order to address elevated LDL-cholesterol and its effects on cardiovascular disease, we aim to educate people about the importance of lowering their cardiovascular risk by monitoring and managing their LDL-cholesterol levels.

Working Here

We’re reaching goals by attracting the best and brightest minds in the industry to work on the forefront of cardiovascular care. If you are interested in joining the Esperion team of innovative colleagues who are passionately committed to making a difference in patients’ lives.